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Conventional surgical therapy for advanced renal venous 
tumor thrombi results in high morbidity, so there is a need 
for less invasive techniques. This report presents the first 
case of a successful inferior vena cava (IVC) tumor throm-
bus removal without complications with balloon catheter 
(BC) via internal jugular vein (IJV), called the venous tumor 
thrombus pushing with balloon catheter (VTTP BC). Un-
der the control of transesophageal echocardiogram and 
fluoroscope, a balloon catheter was sleeved on the guide 
wire, which was already inserted into the right internal jug-
ular vein (IJV) and was driven distally above the IVC tumor 
thrombus. The balloon was inflated to occlude the IVC for 
prevention of pulmonary embolization. After the occlu-
sion, the guide wire was driven to the cavotomy and was 
opened at the ostium of the right renal vein. It was pulled at 
both ends and stretched to serve as a rail. The balloon was 
gently pushed toward the cavotomy and the thrombecto-
my was completed. This is a less invasive method for treat-
ment of venous tumor thrombus level 3 that can reduce 
surgical time, blood loss, and complication rates compared 
to the existing surgical methods. Also, it can be performed 
without thoracotomy, cardiopulmonary bypass, hypother-
mic circulatory arrest, and liver mobilization.
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Venous tumor thrombus (VTT) develops in 4 to 15% of re-
nal cell carcinomas (RCCs) and usually propagates into the 
renal vein and the inferior vena cava (IVC); in 1% of the cas-
es it even propagates into the right atrium (1). Therapy for 
advanced cases complicated with VTT requires a multidis-
ciplinary approach including a urologist, general, vascular, 
and cardiac surgeon, anesthesiologist, and oncologist. The 
basis of such therapy is a radical nephrectomy and VTT re-
section. Neves and Zincke (2) defined four stages of VTT 
propagation to facilitate the prognosis and therapeutic de-
cision-making: Level 1 – renal vein thrombus, 2 – infrahe-
patic IVC, 3 – intrahepatic IVC, but below the hepatic veins, 
and 4 – above level 3. Level 4 thrombi can be suprahepat-
ic, supradiaphragmatic, or intraatrial. The standard surgical 
technique for the management of level 3 and 4 thrombi is 
thoracoabdominal tumor resection with cardiopulmonary 
bypass (CPB) (3). Due to the high morbidity resulting from 
complications associated with these approaches, new and 
less invasive techniques have been developed (4,5). It was 
found that in patients who had undergone inferior vena 
cava thrombectomy with radical nephrectomy, the level of 
tumor thrombus was not an independent prognostic factor 
(6), but the important prognostic factors were pathologi-
cal stage, nuclear grade, tumor histology, lymph node and 
distant metastatic status, preoperative performance status, 
Charlson comorbity index, and nutritional status of the pa-
tient (7). This report presents the first case of a successful 
IVC tumor thrombus removal without complications with 
balloon catheter (BC) via internal jugular vein (IJV).
ThE PATiENT ANd METhodS
A 58-year-old male patient had a history of hypertension 
and type 1 diabetes. In 2009, he was diagnosed with kid-
ney tumor on both sides and underwent right nephrec-
tomy. The histopathology result was clear cell renal cell 
cancer (RCC), T3N0MX. In April 2010, a left partial resec-
tion of the kidney was performed. Following both surgi-
cal interventions, the patient received chemotherapy as 
an adjuvant oncological treatment with Vinblastin and Ro-
feron A. The VTT was diagnosed in October 2010, the on-
cology treatment regime was changed preoperatively, and 
Stutent was administrated.
Half a year after the second operation, abdominal ultra-
sound and preoperative thoracoabdominal CT scans 
showed a 5 cm-diameter metastasis in the right adrenal 
gland, an IVC tumor thrombus, a left hepatic vein tumor 
thrombus, and four 3 mm large metastases in the lungs 
(Figure 1). MRI and transesophageal endoscopy (TEE) 
were used for the assessment of the proximal extension of 
the VTT. A level 3 tumor thrombus expanding to the he-
patic veins was detected. The patient’s general condition 
was good, but the renal function gradually deteriorated 2 
weeks before surgery. Preoperative se-creatinine was 230 
µmol/L and blood urea nitrogen (BUN) was 15.1 mmol/L 
with glomerular filtration rate (GFR) 25.5 mL/min/L.73 m2, 
sodium 141 mmoL/L, and potassium 5.6 mmol/L.
The goal of the surgery was to normalize the venous flow of 
the left kidney, improve renal function, and reduce tumor 
volume with the removal of both the adrenal gland metas-
tases and the VTT, which would improve the effectiveness 
of the oncological treatment. The surgery was done under 
intratracheal narcosis with an antibiotic prophylaxis (2 g 
ceftriaxone, 500 mg metronidazole). The intervention was 
guided by TEE and fluoroscope. The patient was placed in 
a supine position with additional elevation of the liver area. 
The operation was performed through partial Chevron in-
cision. A 5 cm tumor was found in the right adrenal gland, 
attached to the liver-IVC angle. After the mobilization of 
the duodenum, the infiltrated conglomerate of the lymph 
nodes was dissected from the anterior and right surface of 
the IVC, and the tumorous adrenal gland was removed en 
bloc. The IVC section was looped with a rubber band above 
and below the tumorous infiltrated right renal vein stump. 
The same method was used for the left renal vein, which 
was significantly dilated but the lumen was tumor-free. 
The IVC VTT blanketed the left renal vein opening and did 
FiGurE 1. Preoperative CT scan: upper arrow pointing to the 
inferior vena cava with tumor thrombus, the arrow bellow 
pointing to the metastasis.
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not proliferate into the vein. However, the tumor mass re-
duced the renal vein flow, increased the intravenous pres-
sure, and dilated the vein.
After the ultrasound-guided puncture of the right IJV, un-
der fluoroscopic control a guide wire was introduced and 
steered to the level of the diaphragm (Figure 2). A catheter 
(size (F) 8.5; sheath sizing (F) 16; shaft length 100 cm; balloon 
diameters 30 mm; balloon lengths 6 cm with 2 cm narrowed 
end) (Large Omega NV Valvuloplasty Balloon Catheter, Cook 
Medical Europe Ltd, Limerick, Ireland) was guided until it 
reached the diaphragm, where the balloon was inflated 
(Figure 3). Before the balloon was dilated, 10.000 IU heparin 
sodium was administered for systemic heparinization.
The balloon size was determined by the cava diameter 
measured preoperatively. The balloon was inflated at the 
level of the diaphragm to obstruct the IVC. In the next step, 
the left renal vein, and consecutively the IVC bellow left 
renal vein, were occluded using rubber loops for clamp-
ing. Further bleeding from the hepatic veins was prevent-
ed with the Pringle maneuver. Venotomy was performed 
with an excision of the tumorous right renal vein ostium. 
Following balloon inflation, the guide wire was pushed fur-
ther to the cavotomy and the end of the wire was pulled 
out of the vein (Figure 4). A part of the thrombus was re-
moved through the cavotomy.
During thrombectomy, the wire stretched to serve as rail. 
It was used as a trajectory to deliver pressure on the tumor 
thrombus and was slowly pushed toward to the cavotomy, 
which resulted in successful tumor thrombus removal (Fig-
ure 5). After the partial retraction of the guide wire, the cath-
eter was cut proximally to the inflated balloon and pulled 
out through the IJV. The preoperative CT images showed 
the involvement of the left hepatic vein, so after the com-
pletion of the Pringle maneuver there was a chance for 
embolus dissemination. For this reason, a protective cava-
filter (Braun Aesculap cavafilter, B. Braun Melsungen AG, 
Melsungen & Aesculap AG, Tuttlingen, Germany) was in-
serted through the guide wire to avoid embolization. The 
filter was positioned at the level of the diaphragm above 
FiGurE 2. A guide wire was placed through the right internal 
jugular vein to the level of the diaphragm.
FiGurE 3. A balloon catheter was inserted with the help of the 
guide wire to the level of the diaphragm.
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the opening of hepatic veins. In general, it is not necessary 
to use cava filter during VTT thrombectomy.
After positioning the filter, the guide wire was pulled out 
proximally. Then the cava was clamped above the cavo-
tomy with a rubber loop and the Pringle maneuver was 
loosened up. When the opened cava was explored, no tu-
mor remains were found. After degassing, the cavotomy 
was closed with running stitches. The circulation recovered 
after loosening up the caval exclusion and no signs of em-
bolization were observed. After the suspension of heparin-
ization, drainage and layered closure with continuous su-
ture were done. The surgery lasted 4 hours and 20 minutes. 
The patient received 4 × 200 mL red blood cell concentrate 
and 3 × 200 mL fresh frozen plasma and arrived intubated 
at the intensive care unit. After the surgery, the patient’s 
urine output was 3100 mL. Heparin sodium 750 IU/h was 
administered with an infusion pump for anticoagulation. 
On the first postoperative day, the dose was increased to 
1000 IU/h, the patient was extubated, and the empty cava 
filter was removed. On the third day, mobilization started; 
on the fourth day low-molecular-weight heparin (LMWH) 
was initiated; and on the fifth day the intestinal passage 
began. The patient was released on the eighth day. The 
wound healing was per primam and the stitches were re-
moved on the 14th day. There were no postoperative com-
plications. Renal function returned to normal and the pa-
tient survived one year.
diSCuSSioN
This study shows that our newly developed VTTP BC meth-
od can be applied in cases of level 3 thrombi. The IVC can 
be securely occluded during the operation-with the bal-
loon catheter safely placed above the IVC tumor thrombus 
under fluoroscopic and TEE monitoring, thus avoiding the 
danger of embolization. A further advantage of the VTTP BC 
method is the less invasive resection of thrombi expanding 
above the level of the hepatic veins. After thrombectomy, 
the IVC can be clamped bellow the liver and the IVC resec-
tion and reconstruction can be done if necessary.
FiGurE 4. Following balloon inflation the guide wire was 
pushed further to the cavotomy and then the end of the wire 
was pulled out of the vein.
FiGurE 5. during thrombectomy the wire stretched to serve as 
rail, and was used as a trajectory to deliver pressure and gently 
push the tumor thrombus toward cavotomy, which resulted in 
successful removal.
143Nagy et al: New treatment of renal carcinoma with venous tumor thrombus
www.cmj.hr
The basic therapy for RCC complicated with VTT is radi-
cal nephrectomy combined with tumor thrombectomy, 
though the resection and reconstruction of the IVC and me-
tastasectomy may be necessary. The incidence of perioper-
ative complications depends on the cephalic expansion of 
the VTT. Level 1 and 2 thrombi are easily resectable, with low 
complication rates by laparotomy alone. Level 3 or 4 throm-
bi can be resected with extensive hepatic mobilization or 
the use of CPB. The introduction of CPB (8) and hypother-
mic circulatory arrest (HCA) (9) made dissection of such tu-
mors possible and decreased the incidence of embolization. 
However, CPB prolongs the length of the operation and may 
result in significant blood loss, ischemic lesions in the central 
nervous system and other organs, and postoperative coag-
ulopathy (10). The perioperative complication rate in cases 
combining CPB with HCA can reach 31% (1).
Some research groups have successfully applied endolu-
minal IVC occlusion to reduce morbidity. Zini et al (11) 
applied cavotomy below the level of the thrombus and 
resected level 2 and 3 thrombi under continuous TEE mon-
itoring, occluding the IVC with a balloon catheter pushed 
above the tumor thrombus and pulling the thrombus out 
of IVC. Application of this procedure successfully reduced 
the rate of major complications in VTT resections, includ-
ing embolization. However, Zini’s technique still entails a 
considerable risk of embolism since the catheter is guided 
to the thrombus (12).
Rigberg et al (13) performed suprahepatic IVC exclusion via 
a balloon catheter inserted through the IJV. This technique, 
however, is limited to the treatment of level 2 thrombi, and 
positioning the balloon for proper exclusion is difficult. A 
further problem is the disturbance of hepatic venous efflu-
ence by the suprahepatic occlusion, a complication which 
is challenging for the patient. Also, Pringle’s maneuver is 
not performed. Yang et al (14) applied a less invasive meth-
od, similar to Rigberg’s et al (13), on 10 patients with level 2 
VTT. In this technique, surgeon occludes the suprahepatic, 
infraphrenic IVC with a balloon placed through the IJV. IVC 
occlusion was tolerable in 90% of the cases, and no ma-
jor postoperative complications developed. Eight patients 
were alive and tumor-free at the last follow-up. Metcalfe 
et al (15) modified Yang’s technique by holding the mean 
arterial pressure at a constant value and using an intraop-
erative cavogram. Kanka et al (16) slightly modified these 
methods for the resection of a level 3 VTT. They applied IVC 
exclusion above the level of the thrombus with an inflat-
able balloon inserted through the right IJV. This, however, 
required a sufficient distance between the VTT and the os-
tium of the hepatic veins and could not be applicable in 
cases of long thrombi.
Before VTTP BC method was developed in 2011, the au-
thors had in 10 years performed surgeries in 33 patients to 
remove RCC combined with tumor thrombus in the IVC. 
In these patients, all deaths were caused by the postop-
erative progression of the underlying disease. Neverthe-
less the ten years’ experience with level 3 caval vein tumor 
thrombus indicated that it can be removed by a less ag-
gressive surgical approach (17).
A good candidate for safe thrombectomy procedures is the 
AngioVac (AngioDynamics, Latham, NY, USA) procedure, 
which has already been used for percutaneous removal of 
right atrial and vena caval thrombi, vegetation, and tumors. 
This procedure provides an alternative to open surgical re-
section for high risk patients who are regularly poor surgi-
cal candidates and unsuitable for thrombolysis. Although 
AngioVac can reduce the risk of embolization, it was not 
found to be a better method to reduce the metastasis dur-
ing the removal of tumor thrombi (18,19).
VTTP BC method developed by our team is similar to Zi-
ni’s method (11), since both techniques use balloon cath-
eters. The difference is that in VTTP BC the balloon cath-
eter is inserted into the IJV and used to push out the tumor 
thrombus from the proximal to distal position. In the Zini’s 
method, it is inserted through the cavotomy and pushed 
proximally above the tumor thrombus.
A major disadvantage of VTTP BC is the difficulty of push-
ingthe balloon distally even with strained guide wire. This 
is why the vector of the force in short length in Zini’s meth-
od provides a better movement control than the vector of 
the force on the long axis of the wire in VTTP BC method. 
The use of the catheter without a guide wire is very risky 
since it could perforate the vessel during the forced driv-
ing of the tumor thrombus distally in IVC. Development of 
a proper junction between the end of the balloon inserted 
into IJV, positioned above the tumor thrombus, inflated, 
and a pull-off stalk placed through the cavotomy could 
lead to better results. With such a modification, this meth-
od could also be used with Fogarty’s embolectomy.
In conclusion, this report shows that the less invasive VTTP 
BC method offers significant clinical benefits since it does 
not require the use of thoracotomy, cardiopulmonary by-
pass, hypothermic circulatory arrest, and liver mobiliza-
tion, and can better control the risk of embolization.
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